Cargando…
High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model
Oxygenation through High Flow Delivery Systems (HFO) is described as capable of delivering accurate F(iO2). Meanwhile, peak inspiratory flow [Formula: see text] ) of patients with acute hypoxemic respiratory failure can reach up to 120 L/min, largely exceeding HFO flow. Currently, very few data on t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651462/ https://www.ncbi.nlm.nih.gov/pubmed/34877626 http://dx.doi.org/10.1007/s10877-021-00784-z |
_version_ | 1784611401411592192 |
---|---|
author | Duprez, Frédéric de Terwangne, C. Bellemans, V. Poncin, W. Reychler, G. Sorgente, A. Cuvelier, G. Mashayekhi, S. Wittebole, X. |
author_facet | Duprez, Frédéric de Terwangne, C. Bellemans, V. Poncin, W. Reychler, G. Sorgente, A. Cuvelier, G. Mashayekhi, S. Wittebole, X. |
author_sort | Duprez, Frédéric |
collection | PubMed |
description | Oxygenation through High Flow Delivery Systems (HFO) is described as capable of delivering accurate F(iO2). Meanwhile, peak inspiratory flow [Formula: see text] ) of patients with acute hypoxemic respiratory failure can reach up to 120 L/min, largely exceeding HFO flow. Currently, very few data on the reliability of HFO devices at these high [Formula: see text] are available. We sought to evaluate factors affecting oxygenation while using HFO systems at high [Formula: see text] in a bench study. Spontaneous breathing was generated with a mechanical test lung connected to a mechanical ventilator Servo-i®, set to volume control mode. Gas flow from a HFO device was delivered to the test lung. The influence on effective inspired oxygen fraction of three parameters (F(iO2) 0.6, 0.8, and 1, [Formula: see text] from 28 to 98.1 L/min, and HFO Gas Flows from 40 to 60 L/min) were analyzed and are reported. The present bench study demonstrates that during HFO treatment, measured F(iO2) in the lung does not equal set F(iO2) on the device. The substance of this variation (ΔF(iO2)) is tightly correlated to [Formula: see text] (Pearson’s coefficient of 0.94, p-value < 0.001). Additionally, set F(iO2) and Flow at HFO device appear to significatively affect ΔF(iO2) as well (p-values < 0.001, adjusted to [Formula: see text] ). The result of multivariate linear regression indicates predictors ([Formula: see text] , Flow and set F(iO2)) to explain 92% of the variance of delta F(iO2) through K-Fold Cross Validation. Moreover, adjunction of a dead space in the breathing circuit significantly decreased ΔF(iO2) (p < 0.01). The present bench study did expose a weakness of HFO devices in reliability of delivering accurate F(IO2) at high [Formula: see text] as well as, to a lesser extent, at [Formula: see text] below equivalent set HFO Flows. Moreover, set HFO flow and set F(IO2) did influence the variability of effective inspired oxygen fraction. The adjunction of a dead space in the experimental set-up significantly amended this variability and should thus be further studied in order to improve success rate of HFO therapy. |
format | Online Article Text |
id | pubmed-8651462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-86514622021-12-08 High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model Duprez, Frédéric de Terwangne, C. Bellemans, V. Poncin, W. Reychler, G. Sorgente, A. Cuvelier, G. Mashayekhi, S. Wittebole, X. J Clin Monit Comput Original Research Oxygenation through High Flow Delivery Systems (HFO) is described as capable of delivering accurate F(iO2). Meanwhile, peak inspiratory flow [Formula: see text] ) of patients with acute hypoxemic respiratory failure can reach up to 120 L/min, largely exceeding HFO flow. Currently, very few data on the reliability of HFO devices at these high [Formula: see text] are available. We sought to evaluate factors affecting oxygenation while using HFO systems at high [Formula: see text] in a bench study. Spontaneous breathing was generated with a mechanical test lung connected to a mechanical ventilator Servo-i®, set to volume control mode. Gas flow from a HFO device was delivered to the test lung. The influence on effective inspired oxygen fraction of three parameters (F(iO2) 0.6, 0.8, and 1, [Formula: see text] from 28 to 98.1 L/min, and HFO Gas Flows from 40 to 60 L/min) were analyzed and are reported. The present bench study demonstrates that during HFO treatment, measured F(iO2) in the lung does not equal set F(iO2) on the device. The substance of this variation (ΔF(iO2)) is tightly correlated to [Formula: see text] (Pearson’s coefficient of 0.94, p-value < 0.001). Additionally, set F(iO2) and Flow at HFO device appear to significatively affect ΔF(iO2) as well (p-values < 0.001, adjusted to [Formula: see text] ). The result of multivariate linear regression indicates predictors ([Formula: see text] , Flow and set F(iO2)) to explain 92% of the variance of delta F(iO2) through K-Fold Cross Validation. Moreover, adjunction of a dead space in the breathing circuit significantly decreased ΔF(iO2) (p < 0.01). The present bench study did expose a weakness of HFO devices in reliability of delivering accurate F(IO2) at high [Formula: see text] as well as, to a lesser extent, at [Formula: see text] below equivalent set HFO Flows. Moreover, set HFO flow and set F(IO2) did influence the variability of effective inspired oxygen fraction. The adjunction of a dead space in the experimental set-up significantly amended this variability and should thus be further studied in order to improve success rate of HFO therapy. Springer Netherlands 2021-12-08 2022 /pmc/articles/PMC8651462/ /pubmed/34877626 http://dx.doi.org/10.1007/s10877-021-00784-z Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Research Duprez, Frédéric de Terwangne, C. Bellemans, V. Poncin, W. Reychler, G. Sorgente, A. Cuvelier, G. Mashayekhi, S. Wittebole, X. High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model |
title | High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model |
title_full | High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model |
title_fullStr | High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model |
title_full_unstemmed | High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model |
title_short | High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model |
title_sort | high-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651462/ https://www.ncbi.nlm.nih.gov/pubmed/34877626 http://dx.doi.org/10.1007/s10877-021-00784-z |
work_keys_str_mv | AT duprezfrederic highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel AT deterwangnec highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel AT bellemansv highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel AT poncinw highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel AT reychlerg highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel AT sorgentea highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel AT cuvelierg highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel AT mashayekhis highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel AT wittebolex highflownasalcannulatherapyfactorsaffectingeffectiveinspiredoxygenfractionanexperimentaladultbenchmodel |